MSN data give it the “that’s clever” angle with their headline
Analysis: Aussie cannabis firms go capital light as they roll into Europe
Tread light and invest light we get that but there’s also the element of standard Australian approach of trying to get something for nothing.
Personally if we were the EU we’d be slapping heavy tariffs on Australian product firstly to protect our own producers but also if Australia doesn’t want to play nice with carbon, medical cannabis should also be included in list of products given a slap on the wrist.
At least then the medical cannabis producers in Australia with mates in the Liberal party might be forced to apply a little bit of pressure.
+ EU be warned you don’t want these sorts of cheap aussie shouty ads either- just swap lounge sets for medical marijuana !!
Europe could be a hard market to crack as regulations vary by country, but favourable rulings for medical marijuana and potential demand are promising factors. The companies reckon that establishing an early base there and working with European partners will help them better negotiate different markets and steal a march on larger North American rivals.
Cann Group and MGC Pharmaceuticals are among many firms that have pushed into Europe, recently signing partnerships to distribute medical marijuana products and also exploring a dual-listing in the region.
Europe is much smaller than North America, already battling oversupply, but the market is a draw for Australian companies that contend with an even smaller home base.
“With prospects still limited largely to just the prescription market (in Australia), exports remain key to marijuana firms,” said Jo Paterson, founder and CEO of BOD Australia.
New South Wales-based BOD, valued at just $37 million, entered into distribution partnerships in the United Kingdom, Italy and Netherlands last year. Its stock surged two thirds in the period.